SEO URLwww.firestrike.ai/deals/cybergene-devyser-acquisition-2026
acquisitionAnnounced · Feb 11, 2026molecular diagnosticsSource · CredibleArticle · Factual
Devyser acquires CyberGene
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
CyberGene
Stockholm, Stockholm
Acquirer
Devyser
Full Acquisition
Status
Pending
Devyser agreed to acquire CyberGene. Reported deal value: Undisclosed. Status: Pending. Sector: molecular diagnostics. Target headquarters context: Stockholm, Stockholm, Sweden.
This page summarizes publicly available information about the transaction as of 2026-02-11. Figures and status may change as filings and press coverage update.
February 11, 2026 Devyser Diagnostics AB , a Swedish molecular diagnostics company , today announces that it has entered into an agreement relating to the acquisition of 10 0 percent of the shares in Cybergene AB , a Swedish company within the Level Bio AB group
Deal timeline
Announced
Feb 11, 2026 · devyser.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in molecular diagnostics. Figures and status may change as sources update.
Sources: devyser.com · Primary article · FireStrike proprietary index